Oncology News, Insights, Stories by OncoDaily

Advances in Cell-based Screening 2026
2026-05-06 - 2026-05-07 | AstraZeneca R&D Gothenburg, Pepparedsleden 1, Mölndal, Västra Götaland, 431 50, Sweden
The 6th ELRIG Advances in Cell-based Screening 2026 is a free-to-attend, two-day scientific conference scheduled for May 6–7, 2026, in Gothenburg, Sweden.
Hosted at the AstraZeneca R&D site, this interactive event brings together biologists and chemists from academia and industry to explore the latest advancements in cell-based assays. The technical program focuses on state-of-the-art screening formats and best practices for target identification, target validation, and compound optimization.
While applicable across many therapeutic areas, the methodologies discussed – such as high-content imaging and complex 3D cellular models – are foundational to modern oncology drug discovery and precision medicine research.
Register.

The ESMO Breast Cancer 2026
2026-05-06 08:00 - 2026-05-08 17:00 (Europe/Berlin) | Messe Berlin, Messedamm 22, Berlin, 14055, Germany
Join the global breast cancer community at ESMO Breast Cancer 2026, taking place from 6 to 8 May 2026 in Berlin, Germany, or online.
This international congress will gather top experts, researchers, and clinicians to explore the latest advances in breast cancer care, covering everything from early detection to innovative treatments and survivorship strategies.
The event offers a platform to engage with global leaders, share real-world insights, and help shape the future of breast cancer treatment. The Scientific Committee is co-chaired by Masakazu Toi, Sara Tolaney and Nicholas Turner.

Unlocking Next-Generation Therapies
2026-05-06 10:00 - 14:00 (America/Halifax) | The Ritz-Carlton, Washington, D.C, 1150 22nd St NW, Washington, DC, 20037, United States
The public meeting, “Unlocking Next-Generation Therapies,” is an event co-hosted by Friends of Cancer Research and the Parker Institute for Immunotherapy (PICI), scheduled for Wednesday, May 6, 2026, from 10:00 AM to 2:00 PM ET.
Held at The Ritz-Carlton in Washington, DC, with a virtual option, the meeting will gather experts to explore innovative approaches in cell therapy development and examine how modern regulatory policies and development frameworks can be advanced to accelerate safe and effective treatments for cancer patients.
Register.

NCCN Webinar Series - Treatment Options for Richter Transformation of Chronic Lymphocytic Leukemia
2026-05-06 15:00 - 16:00 (America/Halifax)
NCCN will host a specialized program titled “Optimizing Patient Outcomes – When Prognosis Changes from Good to Poor: Treatment Options for Richter Transformation of Chronic Lymphocytic Leukemia” on May 6, 2026, from 3:00 PM to 4:00 PM EDT.
Because conventional chemotherapy often yields poor responses in Richter transformation (RT), this session focuses on the critical role of novel therapies, including BTK and BCL-2 inhibitors, immune checkpoint inhibitors, and CAR T-cell therapies. Oncology professionals will gain insights into identifying risk factors and interpreting clinical trial data for emerging treatments, with a strong emphasis on how increased clinical trial awareness can help overcome the limited historical data available for this aggressive transformation.
Register now.

Egyptian Society of Surgical Oncology 2026 Conference
2026-05-07 - 2026-05-08 | Tolip Gardens Hotel, Gardenia Compound, Cairo - Suez Road, Nasr City, Cairo, Cairo Governorate, 15121, Egypt
The Egyptian Society of Surgical Oncology (EGSSO) 2026 Conference is the 21st Annual EGSSO Conference, scheduled for May 7–8, 2026, at the Tolip Gardens Hotel in Cairo, Egypt. Organized by the Egyptian Society of Surgical Oncology in collaboration with the National Cancer Institute – Cairo University, this premier scientific event aims to bring together leading oncology professionals from the region and worldwide. The conference will focus on exploring the latest innovations in surgical oncology and cancer management, with core objectives being to highlight new techniques, strengthen scientific collaboration, promote research, and ultimately improve patient outcomes and quality of life.

European School of Oncology Refresher Course on Head and Neck Cancers
2026-05-07 - 2026-05-09 | University Foundation, Rue d'Egmont 11, Brussels, Brussels-Capital Region, 1000, Belgium
The European School of Oncology Refresher Course on Head and Neck Cancers is an intensive, multidisciplinary educational program designed for oncology professionals.
Scheduled for May 7-9, 2026, the course provides a comprehensive overview of the latest diagnostic and therapeutic approaches in the field. Participants engage in interactive, case-based learning through Tumor Board simulations led by expert faculty, fostering collaboration between medical, surgical, and radiation oncologists.

NCCN 2026 Policy Summit: Health Literacy in the Cancer Care Digital Age
2026-05-07 13:00 - 16:00 (America/Halifax)
NCCN will host the 2026 Policy Summit Webinar: Health Literacy in the Cancer Care Digital Age on Thursday, May 7, 2026.
This summit provides an opportunity for stakeholders to thoughtfully explore diverse perspectives related to the importance of health literacy and the implications of the rising dependence on digital care systems and media. Key themes include shared decision-making, culturally tailored communications, and the integration of artificial intelligence systems, alongside strategies to promote health-literate organizations and improve equitable cancer care access and outcomes.
Register now.

Scalp Cooling for Prevention of Hair Loss in Pediatric ALL - Resonance
2026-05-08 09:00 - 10:00 (America/Halifax)
The ALRCaN Global webinar, “Scalp Cooling for Prevention of Hair Loss in Pediatric ALL,” is set for Friday, May 08, 2026, from 09:00 AM to 10:00 AM ET (05:00 PM – 06:00 PM AMT).
Led by Dr. Aditya Kumar Gupta, this session examines the clinical utility and implementation of scalp cooling technologies to mitigate chemotherapy-induced alopecia in children undergoing treatment for Acute Lymphoblastic Leukemia. Organized by the Acute Leukemia Research and Care Network (ALRCaN) and Resonance Health, and supported by Scott Howard, Stacy Cooper, Archie Bleyer, and Dan Douer, this forum allows experts to discuss supportive care strategies and quality-of-life optimizations for pediatric oncology patients.

Leading Innovation for Better Outcomes and Performance in Cancer Care: SPCC
2026-05-09 | Campus Bocconi, Via Roberto Sarfatti, 10, Milan, Lombardy, 20136, Italy
Leading innovation for better outcomes and performance in cancer care is a one-day, onsite event organized by Sharing Progress in Cancer Care (SPCC), scheduled for May 9, 2026, in Milan, Italy. Falling under the category of Leadership and Management, this event is designed to explore innovative approaches and strategies that enhance the efficiency and effectiveness of cancer care delivery.
The workshop provides a platform for healthcare leaders and oncology professionals to discuss performance metrics, patient-centered outcomes, and the integration of cutting-edge technologies into clinical practice. By focusing on organizational excellence and leadership development, the session aims to empower participants to drive meaningful change and improve the overall standard of care within their respective institutions.
Register.

ESMO Preceptorship on Hereditary Cancer Genetics 2026: Lugano
2026-05-11 - 2026-05-12 | Lugano, Switzerland
The ESMO Preceptorship on Hereditary Cancer Genetics 2026 is an intensive educational course scheduled for May 11–12, 2026, in Lugano, Switzerland.
Co-chaired by Judith Balmaña and Marjolijn Ligtenberg, this program is designed to provide oncologists with a comprehensive understanding of the molecular basis of genetic susceptibility to cancer. The technical curriculum focuses on the multidisciplinary management of hereditary cancer syndromes, the identification and diagnosis of germline genetic mutations, and the implementation of evidence-based prevention strategies.
Through a combination of state-of-the-art lectures and interactive clinical case discussions, the course aims to equip participants with the skills necessary to provide personalized care for patients with hereditary cancer risks. Successful applicants benefit from complimentary registration and accommodation, and the event is accredited with 9 ESMO-MORA category 1 points.
Application.

Breast Cancer Now Healthcare Professionals Conference 2026
2026-05-11 09:00 - 16:30 (America/Halifax) | The Birmingham Rep Theatre and the Library of Birmingham, Centenary Square, Birmingham, B1 2EP, United Kingdom
The Breast Cancer Now Healthcare Professionals Conference 2026 is set to take place on Monday, 11 May 2026, at The Birmingham Rep Theatre and the Library of Birmingham.
Under the theme “Innovate, Inspire, Include,” this one-day event offers a dedicated space for clinicians and researchers from across the UK to explore clinical advancements and best practices in breast cancer treatment. Attendees can expect a morning of expert-led plenary sessions on cutting-edge clinical updates, followed by interactive afternoon workshops focused on improving patient access to care and mastering difficult conversations. This conference serves as both a vital networking hub and an educational opportunity for healthcare professionals to gain practical insights they can immediately apply to their roles.

2026 International Drug Repurposing Conference (iDR26): Navigating the Future
2026-05-12 - 2026-05-13 | Maison de la Poste, Rue Picard 7, 1000 Brussels, Belgium, Brussels, Brussels-Capital Region, 1000, Belgium
The 2026 International Drug Repurposing Conference (iDR26): Navigating the Future is a global scientific forum taking place from May 12–13, 2026, in Brussels, Belgium.
Co-organized by the REMEDi4ALL consortium and Beacon for Rare Diseases, the conference focuses on technical advancements in AI-driven drug discovery, biosimilars, and biologics, alongside the regulatory and policy frameworks necessary for patient-centric medicine repurposing.
The agenda features four specialized tracks – Rare Diseases, Industry, Drug Discovery, and the Repurposing Community – designed to bridge the gap between academic research, regulatory approval, and equitable patient access.
Register.

Cancer Genomics, Multiomics and Computational Biology
2026-05-12 - 2026-05-14 | Messe Essen GmbH, Messeplatz 1, Essen, North Rhine-Westphalia, 45131, Germany
The Cancer Genomics, Multiomics and Computational Biology conference, organized by the European Association for Cancer Research (EACR), will take place in Essen, Germany, from May 12-14, 2026. This 7th edition of the conference will showcase the latest breakthroughs in cancer genomics, multiomics, and computational biology. The cutting-edge program will cover topics such as machine learning and artificial intelligence, single-cell and spatial analysis of cancers, cell plasticity, cancer immune genomics, and data integration. The goal is to promote collaboration and accelerate the translation of new scientific discoveries into improved diagnostics and tailored therapies for cancer patients.
You can find more posts featuring EACR on OncoDaily.

ESMO Preceptorship on Head and Neck Cancer 2026: Lugano
2026-05-13 - 2026-05-14 | Lugano, Switzerland
The ESMO Preceptorship on Head and Neck Cancer 2026 is a specialized educational course scheduled for May 13–14, 2026, in Lugano, Switzerland.
This program is designed to provide medical and clinical oncologists with a deep understanding of the management of head and neck cancers, ranging from diagnosis to advanced treatment strategies. The curriculum covers the epidemiology, etiology, and molecular biology of nasopharyngeal cancer (NPC) and head and neck squamous cell carcinoma (HNSCC).
Participants will explore multidisciplinary management approaches, including the roles of surgery, radiation therapy, and systemic therapy, with a particular emphasis on the integration of immunotherapy and the management of rare tumors. The course combines plenary lectures with interactive, case-based sessions to facilitate direct engagement between participants and international experts. Successful applicants receive complimentary registration and accommodation, and the event is accredited with 11 ESMO-MORA category 1 points.
Application.

51st Annual ONS Congress
2026-05-13 - 2026-05-17 | Henry B. Gonzalez Convention Center in San Antonio, 900 E Market St, San Antonio, San Antonio, TX, 78205-2784
The 51st Annual ONS Congress, hosted by the Oncology Nursing Society (ONS), will take place from May 13 to 17, 2026, in San Antonio, Texas, USA.
The conference serves as a key platform for thousands of oncology nursing professionals to learn, network, and exchange knowledge on the latest developments in cancer care across all specialties, focusing on areas like hematologic malignancies, breast cancer, and the integration of new technologies such as artificial intelligence (AI) into clinical practice.
Register.

APPOS Pittsburgh 2026
2026-05-15 - 2026-05-16 | The Westin Pittsburgh, 1000 Penn Ave, Pittsburgh, PA, 15222, United States
The APPOS Pittsburgh 2026 (Advanced Practice Providers Oncology Summit) is a two-day conference scheduled for May 15–16, 2026, at The Westin Pittsburgh Hotel.
Organized by Horizon CME, the summit is designed specifically for advanced practice providers (APPs), including NPs, PAs, pharmacists, and nurses, as well as other members of the multidisciplinary oncology team. The primary purpose of the event is to deliver the latest evidence-based strategies to optimize care and outcomes for patients with cancer, featuring a series of didactic sessions and collaborative networking opportunities.

APPOS Seattle 2026
2026-05-15 - 2026-05-16 | Hilton Bellevue, 300 112th Ave SE, Bellevue, 98004, United States
The APPOS Seattle 2026 (Advanced Practice Providers Oncology Summit) is a two-day continuing education conference scheduled for May 15–16, 2026, at The Hilton Bellevue Hotel.
This summit is organized by Horizon CME and is specifically designed for advanced practice providers (APPs), including NPs, PAs, pharmacists, and nurses, to provide them with the latest evidence-based strategies to improve cancer patient care and outcomes.
The agenda covers diverse topics, including the rising incidence of early-onset colorectal cancer, new treatments for non-small cell lung cancer, managing nutritional impact symptoms, and an APP-led panel on surveillance and survivorship clinics.

ESMO Preceptorship on Colorectal Cancer 2026: Lugano
2026-05-15 - 2026-05-16 | Lugano, Switzerland
The ESMO Preceptorship on Colorectal Cancer 2026: Lugano is a specialized educational course scheduled for May 15–16, 2026, in Lugano, Switzerland.
This course is designed to provide oncologists – particularly young and general oncologists – with a comprehensive understanding of colorectal cancer management from diagnosis to treatment. The technical program includes plenary lectures by international experts and interactive case-based sessions, covering best practices in multidisciplinary management for both adjuvant and metastatic settings, the role of molecular pathology in prognosis, and the optimal sequencing of systemic therapies.
Successful applicants benefit from complimentary registration and accommodation, and the event is accredited with 9 ESMO-MORA category 1 points.
Application.

The ESTRO 2026 Congress
2026-05-15 08:00 - 2026-05-19 17:00 (Europe/Stockholm) | Stockholm, Stockholm, Sweden
The ESTRO 2026, will take place in Stockholm, Sweden from 15 to 19 May, under the theme: “Innovating Radiation Oncology Together.”
The congress will continue ESTRO’s mission of advancing innovation through collaboration—bringing together experts in basic science, translational research, and multidisciplinary cancer care. The program will feature engaging keynote speakers, increased patient involvement, and dynamic interaction among chairs, speakers, and participants to enrich learning.
Stockholm, hosting ESTRO for the first time, offers a vibrant and sustainable setting known for its innovation and efficiency. ESTRO 2026 will also feature Europe’s largest Radiation Oncology industry exhibition, the popular ESTRO 5K run, and the Monday night party. Join us to explore breakthrough research, practice-changing trials, and shape the future of radiation oncology—together.
More posts featuring European Society for Radiotherapy and Oncology on OncoDaily.

Incorporating Immunotherapy Into Upfront Ph-Negative Acute Lymphoblastic Leukemia Therapy
2026-05-15 09:00 - 10:00 (America/Halifax) | NY
The ALRCaN Global webinar, “Incorporating Immunotherapy Into Upfront Ph-Negative Acute Lymphoblastic Leukemia Therapy,” is set for Friday, May 15, 2026, from 09:00 AM to 10:00 AM ET (05:00 PM – 06:00 PM AMT).
Led by Dr. Mark Litzow, this session explores the evolving treatment landscape and clinical integration of immunotherapeutic agents into frontline regimens for patients with Philadelphia chromosome-negative Acute Lymphoblastic Leukemia. Organized by the Acute Leukemia Research and Care Network (ALRCaN) and Resonance Health, and supported by Scott Howard, Stacy Cooper, Archie Bleyer, and Dan Douer, this forum provides a platform for experts to discuss novel therapeutic combinations and the optimization of outcomes in upfront leukemia management.

OPN Oklahoma Texas Chapter Conference 2026
2026-05-16 | The Westin Dallas Stonebriar Golf Resort and Spa, 1549 Legacy Dr, Frisco, TX, 75034, United States
The OPN Oklahoma Texas Chapter Conference 2026 is a regional oncology summit scheduled for May 16, 2026, at The Westin Dallas Stonebriar Golf Resort and Spa in Frisco (Dallas area), Texas.
Organized by the Oncology Pharmacy Network (OPN) in collaboration with Horizon CME, the event is specifically designed for hematology/oncology pharmacy clinicians, including pharmacists and pharmacy technicians. This conference focuses on providing the latest evidence-based strategies and fostering professional networking to optimize patient care in the oncology field.
Register.

Tumor Microenvironment: Identifying Drivers of Progression and Resistance
2026-05-17 - 2026-05-20 | Whistler Conference Centre, 4010 Whistler Way, Whistler, BC (British Columbia), V8E 1J2, Canada
The Keystone Symposia conference, “Tumor Microenvironment: Identifying Drivers of Progression and Resistance,” will be held from May 17–20, 2026, at the Whistler Conference Centre in Whistler, British Columbia, Canada.
This conference will explore the complex interactions between tumor cells and their surrounding microenvironment, focusing on identifying the tumor-intrinsic and extrinsic signaling programs that drive cancer progression and influence systemic host responses, such as aging and immunity.
The meeting aims to highlight innovative experimental and computational tools to study the tumor microenvironment (TME), catalyze cross-disciplinary collaborations, and identify new therapeutic targets and methods for patient stratification.

IARC60 Conference: "Cancer Research into Action"
2026-05-19 - 2026-05-21 | Halle Tony Garnier, 20 Place Docteurs Charles et Christophe Mérieux, Lyon, Auvergne-Rhône-Alpes, 69007, France
The International Agency for Research on Cancer (IARC), part of the World Health Organization, will celebrate its 60th anniversary with the IARC60 Conference, themed “Cancer Research into Action.” The event will take place in Lyon, France, from 19 to 21 May 2026, bringing together leading scientists, researchers, policymakers, and public health professionals from around the globe.
This milestone conference will focus on how cutting-edge scientific discoveries can be effectively translated into tangible outcomes for cancer prevention and control. Discussions will center around three key themes: Discovery and Innovation for Cancer Prevention, Translating Research into Public Health Action, and the Science–Policy Interface for Global Change. Participants will have the opportunity to engage in multidisciplinary dialogue and contribute to shaping the future of global cancer research and policy.
The Call for Abstracts is now open, inviting researchers to submit their work and share insights that can advance cancer prevention worldwide. Further details about registration, including participation fees, are available on the official conference website.”
You can find more posts featuring IARC/WHO on OncoDaily.

EURO Master Course in Pediatric Oncology: Module 2
2026-05-19 - 2026-05-23 | Tashkent, Uzbekistan
The EURO Master Course in Pediatric Oncology: Module 2 is an intensive, multidisciplinary educational program focusing on Central Nervous System (CNS) and extracranial solid tumors in children and adolescents.
Scheduled for May 19–23, 2026, in Tashkent, Uzbekistan, the course is a collaborative effort between the Princess Máxima Center for Pediatric Oncology, St. Jude Global, and the International Academic Hub for Pediatric Cancer in Tashkent, Uzbekistan.
This module aims to provide clinicians from Europe and Central Asia, particularly those in limited-resource settings, with the latest evidence-based practices and treatment protocols to improve pediatric cancer outcomes.
Register.

ESMO Guidelines: Real World Cases Webinar: Metastatic Breast Cancer 2026
2026-05-20
The ESMO Guidelines: Real World Cases Webinar: Metastatic Breast Cancer 2026 is a virtual scientific webinar, scheduled for May 20, 2026, that focuses on the practical application of ESMO Clinical Practice Guidelines (CPG) in the management of metastatic breast cancer (MBC).
Chaired by Evandro de Azambuja, the program features a real-world case presentation by Ana Tecic Vuger, followed by a critical analysis of the current guidelines by Seock-Ah Im. A multidisciplinary panel, including experts Nadia Harbeck and Giuseppe Curigliano, will discuss therapeutic sequencing, decision-making in advanced disease, and strategies for overcoming implementation challenges in daily clinical practice. The session provides oncology professionals with 1 ESMO-MORA category 1 point.
Register.

NCCN Global Policy Webinar - The Growing Cancer Burden in Young Adults
2026-05-21 08:00 - 10:00 (America/Halifax)
The NCCN Global Policy Webinar Series will host a vital session titled “The Growing Cancer Burden in Young Adults” on Thursday, May 21, 2026, from 8:00 to 10:00 AM ET.
This international webinar addresses the alarming rise of early-onset cancers among adolescents and young adults (AYAs), bringing together a multidisciplinary panel of experts to examine the environmental, lifestyle, and systemic factors driving this trend. Attendees will gain insights into regional disparities, age-appropriate screening strategies, and the unique psychosocial challenges faced by the AYA population to help bridge the gap in equitable cancer care globally.
Register now.

2026 Memorial Sloan Kettering Cardio-Oncology Symposium
2026-05-21 08:00 - 2026-05-22 17:00 (America/Halifax) | Mortimer B. Zuckerman Research Center, 417 East 68th Street, New York, NY, 10065, United States
The “2026 Memorial Sloan Kettering Cardio-Oncology Summit” will take place on May 21–22, 2026, at the Zuckerman Research Center in New York City and marks the 7th edition of the cardio-oncology conference in NYC.
Organized by Memorial Sloan Kettering Cancer Center, the summit will feature talks by leading cardio-oncology experts, including IC-OS President Michael Fradley, along with expert-led lectures, interactive case discussions, and networking sessions focused on the latest advances in cancer therapeutics, cardiotoxicity, cardiovascular risk management, and evidence-based approaches to cardio-oncology care.
This symposium is endorsed by the New York State Chapter of the American College of Cardiology (NYACC).
Register now.

MASCC Webinar - The Hidden Burden: Understanding and Treating Cancer Fatigue
2026-05-21 16:30 - 17:30 (America/Halifax)
The upcoming MASCC Webinar, “The Hidden Burden: Understanding and Treating Cancer Fatigue,”will be held on May 21, 2026, at 12:30 PM – 1:30 PM EDT.
Chaired by Maryam Lustberg, the webinar will explore cancer-related fatigue through both clinical and patient-centered perspectives. The session will feature insights from patient advocate Abigail Johnston, JD, alongside expert presentations by Dr. Amber Kleckner on defining fatigue as a syndrome and Dr. Stefano Magno on current management strategies, treatment guidelines, and supportive care approaches. The event will conclude with an interactive Q&A panel discussion and is supported by an independent educational grant from Daiichi Sankyo.
Register now.

Infantile Leukemia: Translating Protocol into Practice Through Clinical Experience - Resonance
2026-05-22 09:00 - 10:00 (America/Halifax)
The ALRCaN (Acute Leukemia Research and Care Network) webinar, titled “Infantile Leukemia: Translating Protocol into Practice Through Clinical Experience,” is scheduled for Friday, May 22, 2026, from 05:00 to 06:00 PM (Armenia Standard Time).
Presented by Fatimah Hashim, this session focuses on the translation of standardized leukemia protocols into real-world clinical practice, specifically addressing the unique challenges of infantile leukemia. This weekly collegial gathering, hosted by Resonance, allows experts to share best practices and clinical insights regarding leukemia and supportive care topics to optimize patient outcomes.

Clinical Ethics: End-of-Life Care
2026-05-28 08:30 - 17:00 (America/Halifax) | Deakin University, 727 Collins Street, Docklands, Melbourne, Victoria, 3000, Australia
The Clinical Ethics: End-of-Life Care short course, organized by Deakin Bioethics, is a specialized interprofessional program scheduled for May 28, 2026.
Designed in collaboration with the End of Life Law for Clinicians providers, the course focuses on the ethical challenges unique to adult end-of-life care. It serves as a practical introduction to decision-making frameworks, utilizing facilitated small-group discussions and real-world case studies to help healthcare professionals navigate complex clinical scenarios.
